Study suggests newborns get COVID-19 protection from mothers previously infected

A study of pregnant women in Philadelphia found that most mothers with COVID-19 antibodies gave birth to newborns with those same antibodies, suggesting women can pass on some level of immunity through the umbilical cord. The research, published Friday in the journal JAMA Pediatrics, examined more than 1,500 women who gave birth at one hospital between April and August. In all, 83 of the women tested positive for COVID-19 antibodies, and 72 of their babies tested positive for antibodies through their cord blood, the researchers found. The women infected earlier in their pregnancies produced newborns with higher concentrations of antibodies.
"What we have found is fairly consistent with what we have learned from studies of other viruses," Scott Hensley, a microbiologist at the Perelman School of Medicine at the University of Pennsylvania and one of the senior authors of the study, told The New York Times. Human trials of COVID-19 vaccines did not include pregnant women, so there's little data to draw on, but in December, researchers reported that antibodies produced after influenza and pertussis (whooping cough) vaccines crossed the placenta easier than COVID-19 antibodies from natural infection.
"What we really want to know is, do antibodies from the vaccine efficiently cross the placenta and protect the baby, the way we know happens in influenza and pertussis," Dr. Denise Jamieson, an obstetrician at Emory University who studies COVID-19, told the Times. If the Philadelphia results are replicated in other studies, it could have implications not just for vaccinating pregnant women but also at what stage of the pregnancy to inoculate them.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
5 slow on the draw cartoons about Democrats' response to Trump
Cartoons Artists take on taking a stand, staying still as a statue, and more
By The Week US Published
-
A road trip through Zimbabwe
The Week Recommends The country is 'friendly and relaxed', with plenty to see for those who wish to explore
By The Week UK Published
-
The assassination of Malcolm X
The Explainer The civil rights leader gave furious clarity to black anger in the 1960s, but like several of his contemporaries met with a violent end
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published